JP2021518116A - 細胞媒介性エキソソーム送達 - Google Patents
細胞媒介性エキソソーム送達 Download PDFInfo
- Publication number
- JP2021518116A JP2021518116A JP2020549608A JP2020549608A JP2021518116A JP 2021518116 A JP2021518116 A JP 2021518116A JP 2020549608 A JP2020549608 A JP 2020549608A JP 2020549608 A JP2020549608 A JP 2020549608A JP 2021518116 A JP2021518116 A JP 2021518116A
- Authority
- JP
- Japan
- Prior art keywords
- cells
- cell
- receptor
- protein
- cell according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4746—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used p53
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1804291.1A GB201804291D0 (en) | 2018-03-16 | 2018-03-16 | Cell-mediated exosome delivery |
| GB1804291.1 | 2018-03-16 | ||
| PCT/EP2019/056634 WO2019175428A1 (en) | 2018-03-16 | 2019-03-15 | Cell-mediated exosome delivery |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021518116A true JP2021518116A (ja) | 2021-08-02 |
| JP2021518116A5 JP2021518116A5 (cg-RX-API-DMAC7.html) | 2022-03-25 |
Family
ID=62017765
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020549608A Pending JP2021518116A (ja) | 2018-03-16 | 2019-03-15 | 細胞媒介性エキソソーム送達 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20200407418A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3765526A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2021518116A (cg-RX-API-DMAC7.html) |
| CN (1) | CN112105648A (cg-RX-API-DMAC7.html) |
| GB (1) | GB201804291D0 (cg-RX-API-DMAC7.html) |
| SG (1) | SG11202008227UA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019175428A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9340799B2 (en) | 2013-09-06 | 2016-05-17 | President And Fellows Of Harvard College | MRNA-sensing switchable gRNAs |
| EP3820495A4 (en) | 2018-07-09 | 2022-07-20 | The Broad Institute Inc. | RNA-PROGRAMMABLE EPIGENETIC RNA MODIFIERS AND THEIR USES |
| US12312584B2 (en) | 2018-10-02 | 2025-05-27 | Exosome Therapeutics, Inc. | cGMP exosome loaded therapeutics for treating sickle cell disease |
| WO2020106772A1 (en) * | 2018-11-19 | 2020-05-28 | Exosome Therapeutics, Inc. | Exosome loaded therapeutics for the treatment of non-alcoholic steatohepatitis, diabetes mellitus type 1 and type 2, atherosclerotic cardiovascular disease, and alpha 1 antitrypsin deficiency |
| US12351837B2 (en) | 2019-01-23 | 2025-07-08 | The Broad Institute, Inc. | Supernegatively charged proteins and uses thereof |
| WO2020152298A1 (en) * | 2019-01-24 | 2020-07-30 | Fundació Hospital Universitari Vall D'hebron - Institut De Recerca | Method for producing enzymes |
| WO2020191241A1 (en) | 2019-03-19 | 2020-09-24 | The Broad Institute, Inc. | Methods and compositions for editing nucleotide sequences |
| WO2020214842A1 (en) | 2019-04-17 | 2020-10-22 | The Broad Institute, Inc. | Adenine base editors with reduced off-target effects |
| US20220259617A1 (en) | 2019-06-13 | 2022-08-18 | The General Hospital Corporation | Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells |
| CN114728174A (zh) * | 2019-09-24 | 2022-07-08 | 加利福尼亚大学董事会 | 具有异源跨膜结构域的受体 |
| US12195723B2 (en) | 2019-11-08 | 2025-01-14 | The Broad Institute, Inc. | Engineered antigen presenting cells and uses thereof |
| BR112023001272A2 (pt) | 2020-07-24 | 2023-04-04 | Massachusetts Gen Hospital | Partículas semelhantes a vírus aprimoradas e métodos de uso das mesmas para entrega às células |
| WO2022206816A1 (zh) * | 2021-03-30 | 2022-10-06 | 南京大学 | 一种用于治疗帕金森的rna质粒递送系统 |
| KR102691113B1 (ko) * | 2021-04-09 | 2024-08-02 | 경북대학교 산학협력단 | 대식세포 유래 세포외 소포체 유사체를 포함하는 모발 재생용 조성물 |
| CN113144293A (zh) * | 2021-05-17 | 2021-07-23 | 中国人民解放军总医院 | 负载干细胞外泌体的丝素纳米纤维水凝胶的制作工艺 |
| GB202107182D0 (en) * | 2021-05-19 | 2021-06-30 | Evox Therapeutics Ltd | Nanoparticle delivery system for production of engineered extracellular vesicles |
| CN113527519B (zh) * | 2021-08-11 | 2023-01-06 | 呈诺再生医学科技(珠海横琴新区)有限公司 | 用于递送rna的靶向外泌体 |
| US20250223584A2 (en) | 2021-12-03 | 2025-07-10 | The Broad Institute, Inc. | Compositions and methods for efficient in vivo delivery |
| CN114107253B (zh) * | 2021-12-17 | 2024-03-15 | 复旦大学附属华山医院 | 一种利用工程细胞进行基因编辑的系统及方法 |
| JP2025519070A (ja) | 2022-05-17 | 2025-06-24 | エンヴェロップ セラピューティクス, インコーポレイテッド | 効率的in vivo送達のための組成物および方法 |
| WO2024077117A1 (en) * | 2022-10-06 | 2024-04-11 | Capricor, Inc. | Method for making vesicles |
| CN116143934B (zh) * | 2023-03-21 | 2023-07-25 | 诺赛联合(北京)生物医学科技有限公司 | 一种干细胞外泌体提取试剂盒及其应用 |
| US12221483B1 (en) * | 2024-01-30 | 2025-02-11 | China Medical University Hospital | Fusion protein and nucleic acid encoding sequence thereof, and uses of the same |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018015535A1 (en) * | 2016-07-21 | 2018-01-25 | Evox Therapeutics Ltd | Extracellular vesicle comprising a fusion protein having fc binding capacity |
| WO2018039247A1 (en) * | 2016-08-23 | 2018-03-01 | The Regents Of The University Of California | Proteolytically cleavable chimeric polypeptides and methods of use thereof |
-
2018
- 2018-03-16 GB GBGB1804291.1A patent/GB201804291D0/en not_active Ceased
-
2019
- 2019-03-15 SG SG11202008227UA patent/SG11202008227UA/en unknown
- 2019-03-15 EP EP19712167.6A patent/EP3765526A1/en not_active Withdrawn
- 2019-03-15 CN CN201980019736.4A patent/CN112105648A/zh active Pending
- 2019-03-15 JP JP2020549608A patent/JP2021518116A/ja active Pending
- 2019-03-15 WO PCT/EP2019/056634 patent/WO2019175428A1/en not_active Ceased
- 2019-03-15 US US16/969,213 patent/US20200407418A1/en not_active Abandoned
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018015535A1 (en) * | 2016-07-21 | 2018-01-25 | Evox Therapeutics Ltd | Extracellular vesicle comprising a fusion protein having fc binding capacity |
| WO2018039247A1 (en) * | 2016-08-23 | 2018-03-01 | The Regents Of The University Of California | Proteolytically cleavable chimeric polypeptides and methods of use thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN112105648A (zh) | 2020-12-18 |
| WO2019175428A1 (en) | 2019-09-19 |
| US20200407418A1 (en) | 2020-12-31 |
| SG11202008227UA (en) | 2020-09-29 |
| GB201804291D0 (en) | 2018-05-02 |
| EP3765526A1 (en) | 2021-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20200407418A1 (en) | Cell-Mediated Exosome Delivery | |
| JP7077404B2 (ja) | Rna治療薬を含むエクソソーム | |
| CN109715211B (zh) | 包含治疗性多肽的外来体 | |
| JP2025072522A (ja) | 環状rna組成物及び方法 | |
| CN112334156A (zh) | 用于亲和纯化的工程细胞外囊泡 | |
| US12599679B2 (en) | Circular RNA compositions | |
| EP3786177A1 (en) | Modified mitochondria and use thereof | |
| KR20190032480A (ko) | 결합능을 갖는 융합 단백질을 포함하는 세포외 소포 | |
| US20210285009A1 (en) | Retrotransposon-based delivery vehicle and methods of use thereof | |
| CN121666232A (zh) | 脂质纳米颗粒制剂和组合物 | |
| JP2022520285A (ja) | 低酸素応答性キメラ抗原受容体 | |
| US20250120915A1 (en) | Engineered delivery vesicles and uses thereof | |
| JP2022531887A (ja) | 安定化されたrna治療薬を含むエキソソーム | |
| US20250073350A1 (en) | Compositions and methods for delivering cargo to a target cell | |
| US20250339554A1 (en) | Compositions and methods for delivering cargo to a target cell | |
| US20260034241A1 (en) | Compositions and methods for in vivo expression of chimeric antigen receptors | |
| KR20250129816A (ko) | 대식세포 특이적 프로모터 및 이의 용도 | |
| AU2024376195A1 (en) | Circular rna compositions | |
| US20250241955A1 (en) | Engineered bifunctional receptors and uses thereof | |
| EP4412627A1 (en) | Enhancing adoptive cell transfer by promoting a superior population of adaptive immune cells | |
| CN116916940A (zh) | 工程化嵌合融合蛋白组合物及其使用方法 | |
| WO2025134168A1 (en) | Genetically modified immune cells for the treatment of tumors and autoimmune diseases | |
| US20260115228A1 (en) | Chimeric Antigen Receptors Targeting CD19 | |
| US20260007610A1 (en) | Cell-derived vesicles engineered with anchor proteins and use thereof | |
| KR20240010698A (ko) | 앵커단백질로 엔지니어링된 세포 유래 베지클 및 이의용도 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220315 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220315 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20230125 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230206 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230508 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20230510 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20230807 |